$0.289
-0.0057 (-1.93%)
At Close: Jun 03, 2026
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2
08:00am, Wednesday, 02'nd Oct 2024
TORONTO and GLIL YAM, Israel , Oct. 2, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors
08:30am, Wednesday, 11'th Sep 2024
TORONTO and GLIL YAM, Israel , Sept. 11, 2024 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and
IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript
01:27pm, Wednesday, 14'th Aug 2024
IM Cannabis Corp. (NASDAQ:IMCC ) Q2 2024 Earnings Conference Call August 14, 2024 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executiv
IM Cannabis Corp. (IMCC) Reports Q2 Loss, Tops Revenue Estimates
10:16am, Wednesday, 14'th Aug 2024
IM Cannabis Corp. (IMCC) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $1.14 per share a year ago.
IM Cannabis Reports Second Quarter Financial Results
08:00am, Wednesday, 14'th Aug 2024
IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO and GLIL YAM, Israel, Aug. 14, 2024 /PRNewswire/ -- IM Cannab
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET
08:30am, Tuesday, 06'th Aug 2024
TORONTO and GLIL YAM, Israel , Aug. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement
08:30am, Monday, 29'th Jul 2024
TORONTO and GLIL YAM, Israel , July 29, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations i
IM Cannabis Shares Surge 586% After 6:1 Consolidation: What Investors Need To Know
02:47pm, Friday, 12'th Jul 2024
IM Cannabis Corp. IMCC, a leading medical marijuana company announced that its common shares are trading on a 6:1 post-consolidated basis.
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis
07:30am, Friday, 12'th Jul 2024
TORONTO and GLIL YAM, Israel , July 12, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel
CSE Bulletin: Consolidation - IM Cannabis Corp. (IMCC)
12:44pm, Tuesday, 09'th Jul 2024
Toronto, Ontario--(Newsfile Corp. - Le 9 juillet/July 2024) - IM Cannabis Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated comm
IM Cannabis Announces Intention to Complete Consolidation
07:30am, Friday, 05'th Jul 2024
TORONTO and GLIL YAM, Israel, July 5, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in
IMC Germany's accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannabis growers for EU-GMP certification, bolstering the company's supply chain wi
IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany
08:30am, Wednesday, 29'th May 2024
Through continuous, active cost management, IMC reduced its annual G&A costs by 49% in 2023 and is now looking to significantly reduce its financial costs. TORONTO and GLIL YAM, Israel , May 29, 2024
IM Cannabis Corp. (IMCC) Q1 2024 Earnings Call Transcript
08:49am, Saturday, 11'th May 2024
IM Cannabis Corp. [IMCC] Q1 2024 Earnings Conference Call May 8, 2024 9:00 AM ET Company Participants Oren Shuster - CEP Uri Birenberg - CFO Anna Taranko - IR Conference Call Participants Scott fortun
IM Cannabis Corp. (IMCC) Reports Q1 Loss, Tops Revenue Estimates
10:11am, Wednesday, 08'th May 2024
IM Cannabis Corp. (IMCC) came out with a quarterly loss of $0.16 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago.
Sign In
Buy IMCC